2018
DOI: 10.3390/molecules23081963
|View full text |Cite
|
Sign up to set email alerts
|

Evolution of In Silico Strategies for Protein-Protein Interaction Drug Discovery

Abstract: The advent of advanced molecular modeling software, big data analytics, and high-speed processing units has led to the exponential evolution of modern drug discovery and better insights into complex biological processes and disease networks. This has progressively steered current research interests to understanding protein-protein interaction (PPI) systems that are related to a number of relevant diseases, such as cancer, neurological illnesses, metabolic disorders, etc. However, targeting PPIs are challenging… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
75
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 92 publications
(79 citation statements)
references
References 366 publications
(261 reference statements)
1
75
0
1
Order By: Relevance
“…adenine [65]. Consistent with our observations in mammalian cells, the linear d PMI-δ peptide and the double stapled d PMI-δ (1)(2)(3)(4)(5)(9)(10)(11)(12) peptide had no effect on p53-Mdm2 interaction ( Figure 9A-B). In contrast, the d PMI-δ (1,5,12) peptide completely prevented the growth of yeast cells expressing p53/Mdm2 at 12.5 µM ( Figure 9C, left panel).…”
Section: )/Mdm2 Interaction Inhibits Growth Of Yeast Cells In a Nutsupporting
confidence: 91%
See 4 more Smart Citations
“…adenine [65]. Consistent with our observations in mammalian cells, the linear d PMI-δ peptide and the double stapled d PMI-δ (1)(2)(3)(4)(5)(9)(10)(11)(12) peptide had no effect on p53-Mdm2 interaction ( Figure 9A-B). In contrast, the d PMI-δ (1,5,12) peptide completely prevented the growth of yeast cells expressing p53/Mdm2 at 12.5 µM ( Figure 9C, left panel).…”
Section: )/Mdm2 Interaction Inhibits Growth Of Yeast Cells In a Nutsupporting
confidence: 91%
“…From the 6 stapled peptides designed we found that two, d PMI-δ(1-5) and d PMI-δ(5-12), both exhibited improved binding and cellular properties. We introduced an addition staple between positions 9 and 12 (i+3) in d PMI-δ (1)(2)(3)(4)(5) resulting in a d PMI-δ(1-5,9-12) double stapled peptide [ Figure 8]. Combining d PMI-δ(1-5) and d PMI-δ(5-12) resulted in a stitched peptide, d PMI-δ (1,5,12), with the common attachment point for the two staples localised at residue 5 [ Figure 8].…”
Section: Several Double-stapled Peptides Have Been Shown To Successfumentioning
confidence: 99%
See 3 more Smart Citations